Starting from August 1, 2022, TIPO Will Implement WIPO Standard ST.26 for Nucleotide and/or Amino Acid Sequence Listings Disclosed for Invention Patent Applications - 2022.07.18 - Lewis & Davis Patent Attorneys Office
IP Information

If you have any enquiries or suggestions, please feel free to contact is via the form.

Starting from August 1, 2022, TIPO Will Implement WIPO Standard ST.26 for Nucleotide and/or Amino Acid Sequence Listings Disclosed for Invention Patent Applications - 2022.07.18

WIPO has announced that the WIPO Standard ST.26 applies to international applications with nucleotide and/or amino acid sequence listing filed on or after July 1, 2022.

TIPO will fully implement WIPO Standard ST.26 from August 1, 2022. All nucleotide and/or amino acid sequences presented in invention patent applications must comply with the new Standard.

For more information, Please visit:
Taiwan Intellectual Property Office-News-Starting from August 1, 2022, TIPO Will Implement WIPO Standard ST.26 for Nucleotide and/or Amino Acid Sequence Listings Disclosed for Invention Patent Applications




If you have any enquiries or suggestions, please feel free to contact is via the form.

遠碩專利師事務所  
Lewis & Davis Patent Attorneys Office 12F, No. 290, Fuxing North Road, Taipei 10478, Taiwan
TEL:+886-2-2517-5955 FAX:+886-2-2517-8517 E-mail:This email address is being protected from spambots. You need JavaScript enabled to view it.